# Use Of SB-705498 In The Acute Treatment Of Migraine

> **NCT00269022** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 70 (—)

## Conditions studied

- Migraine, Acute

## Interventions

- **DRUG:** SB-705498

## Key facts

- **NCT ID:** NCT00269022
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 70 (—)
- **Last updated:** 2009-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00269022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00269022, "Use Of SB-705498 In The Acute Treatment Of Migraine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00269022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*